CS logo
small CS logo
Family Medicine of SayeBrook

Myrtle Beach, South Carolina, United States
Medical clinic in Socastee, South Carolina
106 Lansford Pl # 100, Myrtle Beach, SC 29588

About Family Medicine of SayeBrook


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Boehringer Ingelheim
2
Kowa Research Institute, Inc.
2
Urovant Sciences GmbH
2
Allergan
1
Anji Pharma
1
Elcelyx Therapeutics, Inc.
1
Novartis Pharmaceuticals
1
Total Rows: 8

Clinical Trials at Family Medicine of SayeBrook


During the past decade, Family Medicine of SayeBrook conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 8 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2211222200002200110011110044Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GLORIA-AF Registry Program - Second and Third Phases
2011-11-07
2020-01-10
Completed
37,235
Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 Diabetes
2012-06-01
2015-01-01
Completed
315
Longitudinal Study of Patients With Opioid-Induced Constipation
2012-10-01
2014-12-01
Completed
520
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
2015-01-29
2016-06-09
Completed
393
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
2015-09-01
2016-09-01
Completed
571
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment
2016-11-26
2019-07-05
Completed
471
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
2017-09-20
2020-09-30
Completed
714

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Family Medicine of SayeBrook" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Family Medicine of SayeBrook" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "HealthCore-NERI" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAstraZeneca: 2AstraZeneca: 2Boehringer Ingelheim: 2Boehringer Ingelheim: 2Kowa Research Institute, Inc.: 2Kowa Research Institute, Inc.: 2Urovant Sciences GmbH: 2Urovant Sciences GmbH: 2Allergan: 1Allergan: 1Anji Pharma: 1Anji Pharma: 1Elcelyx Therapeutics, Inc.: 1Elcelyx Therapeutics, Inc.: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsBrigham and Women'sHospital: 1Brigham and Women'sHospital: 1HealthCore-NERI: 1HealthCore-NERI: 1

Clinical Trials Conditions at Family Medicine of SayeBrook


According to Clinical.Site data, the most researched conditions in "Family Medicine of SayeBrook" are "Overactive Bladder" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Diabetes Mellitus" (1 trials) and "Diabetes Mellitus Complications" (1 trials). Many other conditions were trialed in "Family Medicine of SayeBrook" in a lesser frequency.

Clinical Trials Intervention Types at Family Medicine of SayeBrook


Most popular intervention types in "Family Medicine of SayeBrook" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "K-877" (2 trials), "Metformin IR" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "Dapagliflozin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Family Medicine of SayeBrook


The vast majority of trials in "Family Medicine of SayeBrook" are 12 trials for "All" genders.

Clinical Trials Status at Family Medicine of SayeBrook


Currently, there are NaN active trials in "Family Medicine of SayeBrook". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Family Medicine of SayeBrook, 1 suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Family Medicine of SayeBrook, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 1Recruiting: 1Suspended: 1Suspended: 1Terminated: 1Terminated: 1